Navigation Links
HIV Treatment Said to Increase Heart Attack Risk

A common treatment option for HIV patients is associated with an increased risk for a heart attack, according to a new study. However, researchers say the benefit of the treatment outweighs the risk of a //heart attack for most patients.

Combination antiretroviral therapy substantially improves the prognosis of HIV-infected patients at risk for AIDS. Before this therapy was available, the annual mortality rate among patients with HIV infection exceeded 20 percent.

In the current research, the mortality rate was 2 percent. While the benefits of combination antiretroviral therapy are clear, there is a concern about the treatment being associated with adverse side effects. These side effects include high cholesterol and triglycerides, insulin resistance and diabetes. These problems can lead to cardiovascular problems.

Researchers in Denmark conducted a study to determine if exposure to combination antiretroviral treatment increases the risk of a heart attack. They looked at information on more than 23,000 patients from 11 previous studies. They collected follow-up information on the patients about their HIV and if they had suffered a heart attack.

Researchers collected data over a period of 36,199 person-years. They found 126 patients had a heart attack. They say the incidence of a heart attack increased with longer exposure to combination antiretroviral therapy. They also say factors such as older age, current or former smoking, previous cardiovascular disease and male sex also increased the risk for a heart attack. Furthermore, a higher cholesterol level, a higher triglyceride level and diabetes were associated with an increased risk for a heart attack.

Investigators conclude combination antiretroviral therapy was independently associated with a 26-percent increase in the rate of a heart attack. However, they point out the risk has to be balanced against the benefits from the antiretroviral treatment. They add tha t heart disease can take decades to develop, so further follow-up research is needed to determine the absolute risk of cardiovascular disease.


Related medicine news :

1. Advances in Treatment of Cataracts
2. Recommendations for Treatment of Blood Pressue
3. Treatment for Menieres disease
4. Treatment for pre-menstrual syndrome is ineffective
5. Better Treatment for obesity
6. Gene Treatment for Heart Disease
7. More People Seeking Treatment for Depression
8. Focused Treatment For Childhood Cancer
9. Inadequate Drug Treatment For Youth
10. FDA Approves New surgery Treatment for Farsightedness
11. Treatment of antibiotics ineffectual in bronchitis
Post Your Comments:

(Date:12/1/2015)... ... December 01, 2015 , ... ... and hematology continuing medical education (CME), today announced that the first annual School ... New York. , “The prevention, detection and treatment of gastrointestinal cancers are undergoing ...
(Date:12/1/2015)... , ... December 01, 2015 , ... Growth in medical ... due to decreases in utilization of hospital and nonhospital care, according to a recent ... Medical Benchmarks for Louisiana, 16th Edition , found medical payments per claim with more ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... images have been lifted as IMAGE Information Systems launches MED-TAB™ -- the world’s ... America Annual Meeting from November 29 to December 4, 2015. , MED-TAB ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... Inc. (“Visage”), a wholly owned subsidiary of Pro Medicus Ltd. (ASX: PME), has ... the Radiological Society of North America (RSNA) 2015 annual meeting through December 3 ...
(Date:12/1/2015)... (PRWEB) , ... December 01, 2015 , ... ... clinical solutions for the care management and population health arenas, is pleased to ... clinical and cost containment services, has successfully implemented the ACUITY Complete Care™ Management ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... , Dec. 2, 2015  A combination of detailed ... the first time in the surgical planning for separation of ... annual meeting of the Radiological Society of North ... --> Conjoined twins, or twins whose bodies are connected, ... rates are low and separating them through surgery is extremely ...
(Date:12/1/2015)... , Dec. 1, 2015  A large study ... drug tamoxifen while taking an antidepressant found no increased ... today in The Journal of the National Cancer Institute. ... Tamoxifen is a commonly prescribed generic drug taken by ... developing a recurrence. Tamoxifen is recommended for five years, ...
(Date:12/1/2015)... Wash. and VANCOUVER , ... Committee (DMC) meeting, OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI ... is continuing based on the pre-planned interim futility analysis ... review, no new safety issues were identified by the ... all analyses and final results are expected in the ...
Breaking Medicine Technology: